期 |
栏目 |
标题 |
文件 |
卷 2, 编号 1 (2005) |
Articles |
Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh |
|
卷 3, 编号 1 (2006) |
Articles |
Sindrom obstruktivnogo apnoe vo vremya sna i arterial'naya gipertenziya |
|
卷 5, 编号 3 (2008) |
Articles |
Klinicheskiy sluchay: primenenie postoyannogo polozhitel'nogo davleniya v dykhatel'nykh putyakh pri sindrome obstruktivnogo apnoe sna |
|
卷 7, 编号 3 (2010) |
Articles |
Vliyanie SRAR-terapii na «sosudistye» faktory riska serdechno-sosudistykh oslozhneniy u patsientov s tyazhelym sindromom obstruktivnogo apnoe sna i arterial'noy gipertenziey |
|
卷 13, 编号 2 (2016) |
Articles |
Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 13, 编号 4 (2016) |
Articles |
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 13, 编号 4 (2016) |
Articles |
Coagulation markers in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 14, 编号 1 (2017) |
Articles |
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 8, 编号 1 (2011) |
Articles |
Effektivnost' kompleksnoy medikamentoznoy i CPAP-terapii u patsientov s arterial'noy gipertoniey 2-3-y stepeni i tyazheloy stepen'yusindroma obstruktivnogo apnoe vo vremya sna. |
|
卷 9, 编号 1 (2012) |
Articles |
Dostizhenie tselevykh urovney arterial'nogo davleniya na fone priema fiksirovannoy kombinatsii perindoprila 10 mg i indapamida 2,5 mg u patsientov s nekontroliruemoy arterial'noy gipertenziey 2-3-y stepeni |
|